Skip to main content
OpenTrials

Clinical trial condition

Pituitary ACTH Hypersecretion

Explore clinical trials studying Pituitary ACTH Hypersecretion. Study availability and eligibility vary by location and protocol.

47 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Pituitary ACTH Hypersecretion trial results

Completed

Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease

NCT02697734

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing's Disease, +6 more
Locations
  • University of Colorado Endocrinology Clinical Trials Unit Aurora, Colorado, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Columbia University Medical Center New York Presbyterian Neuroendocrine Unit New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 36 locations
View Trial Details
Completed

Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease

NCT00171951

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing Disease, +6 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health & Sciences University Dept.ofOregonHealth&SciencesU. Portland, Oregon, United States
  • University of Pennsylvania Medical Center Philadelphia, Pennsylvania, United States
  • Novartis Investigative Site Paris, France
View Trial Details
Completed

Treatment for Endogenous Cushing's Syndrome

NCT01838551

Conditions
Brain Diseases, Central Nervous System Diseases, Endocrine System Diseases, +6 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Medical Center Ann Arbor, Michigan, United States
View all 42 locations
View Trial Details
Completed

Safety and Efficacy of LCI699 in Cushing's Disease Patients

NCT01331239

Conditions
Adrenal Gland Diseases, Adrenocortical Hyperfunction, Brain Diseases, +9 more
Locations
  • Northwestern University Endo, Metabolism and Molecular Chicago, Illinois, United States
  • Massachusetts General Hospital Neuroendocrine Unit Boston, Massachusetts, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Oregon Health and Science University SC Portland, Oregon, United States
View Trial Details
Completed

Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

NCT02060383

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +14 more
Locations
  • Diabetes and Endocrine Associates La Mesa Location Multiple Locations, California, United States
  • LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 Torrance, California, United States
  • Coastal Metabolic Research Centre SC Ventura, California, United States
  • East Coast Institute for Research East Coast Inst. for Res(ECIR) Jacksonville, Florida, United States
View all 43 locations
View Trial Details
Completed

An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.

NCT01582061

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +15 more
Locations
  • Advanced Research, LLC Peoria, Arizona, United States
  • St Josephs Hospital & Medical Center St Joes Phoenix, Arizona, United States
  • University of California at Los Angeles UCLA Tiverton Los Angeles, California, United States
  • LA Biomedical Research at Harbor UCLA Medical Center Torrance, California, United States
View all 65 locations
View Trial Details
Completed

Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease

NCT01374906

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing's Disease, +6 more
Locations
  • ClinTriCo Phoenix, Arizona, United States
  • University of California at Los Angeles UCLA Tiverton Los Angeles, California, United States
  • Harbor-UCLA Medical Center LA Biomed Torrance, California, United States
  • Emory University School of Medicine/Winship Cancer Institute G2304 - C2301 Atlanta, Georgia, United States
View all 82 locations
View Trial Details

Related conditions